Charles C. Wu
Chief Executive Officer at Gyre Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Gyre Therapeutics Inc., 3 years.
Chief executive roles
Weak · grade F
Out of 100, from shareholder return, dividends, growth and acquisitions.
Partial: only 35% of the scoring weight is on file.
- Revenue growth 20%
- 60
- Earnings growth 15%
- 15
4.5% a year in revenue
-12.6% a year in earnings per share
35% of the scoring weight is on file. Figures cover December 2022 – December 2025.
Questions about Charles C. Wu
What boards is Charles C. Wu on?
Charles C. Wu sits on the board of Gyre Therapeutics Inc.
Has Charles C. Wu been a CEO?
Yes — Charles C. Wu was CEO of Gyre Therapeutics Inc. (2023 – 2026).
How long has Charles C. Wu served on boards?
Our records show at least 3 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.